Obesity White Papers & Case Studies
-
Start Strong And Keep Your Study Moving
6/13/2025
Plan face-to-face, virtual, and hybrid life sciences events with precision using an end-to-end service that plans everything from investigator meetings to advisory boards and incentive trips.
-
Simplify Your Sites Operations, Patient Payments, Travel, And Logistics
6/13/2025
Simplify patient support in clinical trials through comprehensive expense management, travel coordination, and site services designed to reduce the burden on sites and participants.
-
Precision Project Management In Action
6/12/2025
Discover how a tailored, risk-based project management approach was used to overcome the challenges of a complex Phase I/IIa FIH multi-country study of an advanced therapy medicinal product (ATMP).
-
Your Global CRO Partner In Ophthalmology
6/11/2025
Ophthalmic drug and device development demands precision, agility, and deep therapeutic knowledge. Discover how our focused ophthalmology expertise can support your next clinical breakthrough.
-
Leveraging AI To Transform Neurodegenerative Drug Development
6/11/2025
Explore how AI is redefining the development pipeline for neurodegenerative diseases (NDDs), offering a path forward in the quest for effective, disease-modifying treatments.
-
Optimizing EDC Strategy And Data Collection for a Rare Disease Trial
6/11/2025
Explore how Veristat created a forward-looking roadmap for EDC and CRFs integration for a small biotech sponsor, ensuring a future-ready data ecosystem without overcomplicating current operations.
-
When Science And Humanity Become Inseparable
6/11/2025
Learn how kindness transformed the clinical trial experience for pediatric rare disease participants in a global study.
-
Wearables For Optical Cardiovascular Monitoring
6/10/2025
Wearable digital health technologies (DHTs) are transforming cardiovascular health monitoring by enabling continuous, real-world assessment through optical sensors like photoplethysmography (PPG).
-
Deriving Reliable Clinical Outcome Scores From Continuous DHT Data
6/10/2025
DHT-derived endpoints, especially percentile-based metrics, hold promise for robust, scalable measurement in clinical trials—provided they're chosen statistically and with adherence in mind.
-
Running A 697-Patient MS Study Through Crisis And Complexity
6/10/2025
Review an ongoing Phase III open-label extension study evaluating the long-term safety and efficacy of ublituximab in patients with relapsing multiple sclerosis.